52992-82-2 Usage
General Description
Acetylisocupressic acid is a natural chemical compound found in the resin of certain conifer trees, including the cupressus and juniper species. It has been identified as a potent inhibitor of the enzyme 15-lipoxygenase, which plays a role in the inflammation process. This makes acetylisocupressic acid a potential candidate for the development of anti-inflammatory drugs. Studies have also shown that this compound exhibits antioxidant properties, which could contribute to its ability to protect cells from oxidative damage. Additionally, acetylisocupressic acid has demonstrated antimicrobial activity against a variety of bacteria and fungi, suggesting its potential for use in treating infections. Further research on this compound may reveal additional therapeutic applications and potential benefits for human health.
Check Digit Verification of cas no
The CAS Registry Mumber 52992-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,9 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52992-82:
(7*5)+(6*2)+(5*9)+(4*9)+(3*2)+(2*8)+(1*2)=152
152 % 10 = 2
So 52992-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C22H34O4/c1-15(12-14-26-17(3)23)8-10-19-16(2)9-11-20-18(21(24)25-5)7-6-13-22(19,20)4/h12,18-20H,2,6-11,13-14H2,1,3-5H3/b15-12+/t18-,19-,20+,22-/m0/s1
52992-82-2Relevant articles and documents
Potential antitumor promoting diterpenoids from the stem bark of Thuja standishii
Iwamoto, Manabu,Minami, Toshifumi,Tokuda, Harukuni,Ohtsu, Hironori,Tanaka, Reiko
, p. 69 - 72 (2003)
Six diterpenes, including one new natural product, were isolated from a CHCl3 extract of the stem bark of Thuja standishii. The new compound has been characterized as 15-oxolabda-8(17),13Z-dien-19-oic acid. The known compounds were identified as ferruginol (2), sugiol (3), isocupressic acid (4), sandaracopimaric acid (5) and 15-oxolabda-8(17),13E-dien-19-oic acid (6). Compounds 2-5 and the derivatives 4a and 4b were tested for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA). Compounds 2, 3, 4 and 5 showed strong inhibitory effect on EBV-EA induction (100% inhibition at 1000 mol ratio/TPA).